Maximizing the benefits of using biosimilars in Egypt.

ABSTRACT:

Background

Biosimilars constitute a pathway for sustainable financing of healthcare systems in the era of expensive biologics. However, such a pathway is not free of challenges. Since the biosimilars market is expanding in Egypt, there is an urgent need for a policy framework to optimize their use and diffusion in the market. We aim to characterize a national framework based on the experiences of other countries and consultation with local experts.

Methods

A narrative literature review was conducted to identify biosimilars' policy elements worldwide. A workshop was organized with experts to discuss the narrative review findings and create consensus on recommendations.

Results

The narrative literature review highlighted the need for biosimilar policy actions in four ar

SUBMITTER: Fasseeh AN 

PROVIDER: S-EPMC10291771 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature